Setanaxib TRANSFORM study now enrolling

Setanaxib TRANSFORM study now enrolling

Setanaxib TRANSFORM study now enrolling

The purpose of this clinical research study is to evaluate the effects of an investigational product (setanaxib) as a potential additional treatment for PBC. The study is now enrolling in Ontario:  Toronto, London, North Bay and in Calgary, Alberta. To learn more about the TRANSFORM study and whether or not you might be able to participate, click here.